IF YOU RECEIVED THIS FACSIMILE IN ERROR, PLEASE CALL IMMEDIATELY. ADMISSION INSTRUCTIONS: Admitted to Dr.

Transcription

1 ADMISSION INSTRUCTIONS: Admitted to Dr. Procedure: Right Hip Left Hip CODE STATUS: Full DNR level of intervention DIET: Dysphagia screen consult SLP High protein, high energy Regular Nutrient dense Boost 120mL BID; stop POD 4 Dietitian may adjust diet Other: ACTIVITY: Mobilize. Full weight bear Partial weight bear Non-weight bearing for weeks Hip Precautions: None Yes for weeks CONSULTS: Social Worker Dietitian Physiotherapist Occupational Therapist Pharmacist MONITORING: Vitals, Neurovascular and Pain Assessment on admission, Q4H x 24 hrs Skin assessment (Braden scale) Complete Confusion Assessment Method (CAM) assessment Q shift as per hip fracture pathway LABORATORY: CBC, serum creatinine, urea, electrolytes, glucose, phosphate, magnesium POD 1 and 2 If on warfarin, INR daily starting on POD 2 DIAGNOSTICS: X-ray AP pelvis and lateral of left hip right hip _ TREATMENTS: Titrate O 2 to maintain oxygen saturation greater than or equal to 93% or Urinary Foley catheter: Remove prior to leaving PACU Remove POD 1 at 06:00 Leave catheter in if one or more indicators met: 1. Critically ill-accurate output required. 2. Advanced pressure ulcer & incontinent 3. End of life comfort. 4. Severe pain. Reassess need for catheter daily. If no Foley catheter in situ or post foley removal, assess patient for ability to void Q6H using bladder scanner, if urine output less than 200 ml in 6 hours, notify MD - avoid bedpans If unable to void, bladder discomfort or voiding small amounts: bladder scan. If bladder volume is greater than 300 ml, perform straight intermittent catheterization x 3 PRN. If retention is not relieved by 2 nd in and out catheterization, leave 3 rd catheter in place and inform MD Dressing: Change on POD OR Change dressing only if saturated Remove staples POD 10 to 14 if wound edges are well approximated Other: VCH.RD.RH.0105 NOV.2014 CHART COPY Page 1 of 5

2 TREATMENTS (continued): PNEUMONIA PREVENTION: Patient to brush teeth and tongue within 4 hours of OR. If dependant for personal care, clean teeth and tongue BID. Rinse mouth, moisturize lips Q4H (avoid petroleum based products) Head of bed elevated minimum 30 degrees Deep breathing and coughing exercises 5 to10 times per hour and PRN INTRAVENOUS: Infuse IV dextrose 5%- sodium chloride 0.9% at ml/hour Infuse sodium chloride 0.9% at ml/hour Infuse IV ml/hour Convert IV to saline lock when oral intake adequate (1200 to 1500 ml/24 hour unless fluid restricted). Discontinue when antibiotics completed MEDICATIONS: No meperidine, No benzodiazepines unless used by patient prior to admission Analgesic: acetaminophen 650 mg PO/ rectal QID while awake HYDROmorphone 0.5 to 1 mg PO or 0.25 to 0.5 mg subcutaneously Q4H Regular HYDROmorphone 0.5 to 1 mg PO or 0.25 to 0.5 mg subcutaneously Q2H PRN Other: For Respiratory Depression/ Over Sedation - sedation scale greater than 2 and/or respiratory rate less than 8/min: Hold Narcotics. Give naloxone 0.04 mg IV or 0.1 mg subcutaneous every 2 minutes PRN (max X4) until sedation scale is 2 or less and respiratory rate is greater than 8/min Start Oxygen by face mask at 10 litres/min NOTIFY PHYSICIAN STAT Reassess respiratory rate and sedation scale every 15MIN for one hour following final dose of naloxone then Q1H x 4 hours Antiemetic: HS Sedation: ondansetron 4 mg IV/PO Q8H PRN metoclopramide 10 mg IV/PO Q6H PRN Avoid HS sedation unless used by patient prior to admission (order same medication) zopiclone 3.75 mg PO HS PRN for insomnia. May repeat x 1 Constipation Protocol (as per the completed Constipation Protocol order form VCH.RD.RH.0019) VCH.RD.RH.0105 NOV.2014 CHART COPY Page 2 of 5

3 MEDICATIONS: Antibiotic: No postoperative antibiotics (as per Regional Surgical Antibiotic Prophylaxis Guidelines) Date/time of pre-op prophylactic antibiotic dose: cefazolin 1 g IV Q8H x 2 doses (1 st dose 8 hours after pre-op dose. Adhere to times) OR if penicillin/ cephalosporin allergy (Select one) clindamycin 600 mg IV Q8H x 2 doses (1 st dose 8 hours after pre-op dose. Adhere to times) vancomycin 1 g IV to be given 12 hours after pre-op dose Delirium: ONLY for patients with persistent agitation with risk of harm or injury and CAM positive. If medication for delirium given, notify MD/NP to investigate/address underlying cause within 24 hours. Medication orders ONLY for persistent agitation with risk of harm or injury: QUEtiapine 6.25 to 12.5 mg PO Q4H PRN to a maximum of mg in 24 hours If unable to use oral route: DO NOT order loxapine or haloperidol in patients with Parkinsons Disease/ Lewy Body Dementia haloperidol 0.25 to 0.5 mg subcutaneously Q2H PRN to a maximum of 1.5 mg/24 hours methotrimeprazine 2.5 to 5 mg subcutaneously Q4H PRN to a maximum of 25 mg/24 hours Other: BONE HEALTH / FRACTURE PREVENTION Begin postoperative day 2 multivitamin with minerals 1 tablet PO daily calcium carbonate 1250 mg PO BID vitamin D 1000 units PO daily Reconcile all medications including Medication Reconciliation Orders from admission. DISCHARGE: Discharge when patient meets clinical pathway discharge criteria Estimated date: VCH.RD.RH.0105 NOV.2014 CHART COPY Page 3 of 5

4 Patient Weight: kg Platelet count: x 10 9 /L on (Date): Refer to VTE Risk Assessment and Thromboprophylaxis Recommendations on page 4 RISK ASSESSMENT: Low risk: Early ambulation; no anticoagulant or mechanical prophylaxis Moderate or High risk: Order anticoagulant prophylaxis unless contraindicated CONTRAINDICATION(S) TO ANTICOAGULANT PROPHYLAXIS (check all that apply): Active bleeding of clinical significance requiring intervention High risk of serious bleeding or bleeding into a critical site (e.g. intracranial, intraspinal, pericardial, intraocular, retroperitoneal, intra-articular) Known major bleeding disorder or acquired coagulopathy (consider Hematology consult) Platelet count less than 50 x 10 9 /L (consider Hematology consult) History of heparin-induced thrombocytopenia (HIT) _see Footnotes and Precaution 7 on reverse_ Patient already receiving therapeutic anticoagulation Other contraindication (specify): Reassess daily to start anticoagulant prophylaxis when contraindication resolves ANTICOAGULANT PROPHYLAXIS: _see Footnotes and Precautions 6 to 9 on reverse_ Give first post-op dose at (time): on (date): dalteparin 5000 units subcutaneous daily at 18:00 until discharge OR for patients with severe renal impairment, heparin 5000 units subcutaneous Q12H until discharge OR Other: Reason: Monitor patients with epidural catheter receiving anticoagulant prophylaxis for symptoms and signs of spinal hematoma Epidural catheter should not be removed within 12 or more hours of a dose of dalteparin or heparin After epidural catheter removal, dalteparin or heparin should not be given for at least 2 hours MECHANICAL PROPHYLAXIS: (only when anticoagulant prophylaxis contraindicated) Sequential compression device (SCD) Mechanical prophylaxis contraindicated (see back for list of contraindications) Apply to lower limb(s) continuously until anticoagulant prophylaxis starts or discharge Interrupt for skin care, assessments, toileting and ambulation only VCH.RD.RH.0105 NOV.2014 CHART COPY Page 4 of 5

5 VTE RISK ASSESSMENT AND THROMBOPROPHYLAXIS RECOMMENDATION Patient Risk Groups (satisfaction of any one or more of the listed criteria) Low Risk Group Day surgery 1 without any VTE risk factors (see below) No reduction in mobility compared to usual state Surgical procedure with a total anesthetic and surgical time of less than 60 minutes with no risk factors for VTE (see below) Moderate or High Risk Group Any medical or surgical patient having had or are expected to have significantly reduced mobility for 3 days or more 2,3 Medical patients with ongoing reduced mobility (compared to their usual state) AND have one or more risk factors for VTE (see below) 2,3 Surgical procedure with a total anesthetic and surgical time of 60 minutes or longer 3-6 Acute surgical admission with an inflammatory or intra-abdominal condition 3-6 Surgical patients with one or more risk factors for VTE (see below) 3-6 Obstetrical Patients with Increased Risk Having one or more risk factors for VTE (see below) Pregnancy-related risk factors: Ovarian hyperstimulation Hyperemesis gravidarum Multiple pregnancy Age 60 years or over Active cancer and cancer treatment Previous VTE Critical Care admission Obesity (BMI over 30 kg/m 2 ) Known thrombophilia First degree relative with VTE Varicose veins with phlebitis Estrogen-containing oral contraception Hormone replacement therapy Acute stroke with immobility (unable to walk independently to the toilet) Peripheral vascular disease with absent pedal pulses Severe peripheral neuropathy Skin breakdown, ulcers, gangrene, cellulitis, or dermatitis Preeclampsia Emergency caesarean section RISK FACTORS FOR VTE One or more significant medical conditions: Sepsis or severe acute infection Heart disease Respiratory pathology Inflammatory condition Rheumatological disease Nephrotic syndrome Antiphospholipid syndrome Acute Stroke CONTRAINDICATIONS FOR MECHANICAL PROPHYLAXIS Thromboprophylaxis Recommended Early ambulation Mechanical or LMWH (heparin if egfr less than 10 ml/min) 4-9 Consider LMWH (heparin if egfr less than 10 ml/min) 4-9 Skin grafting within last 3 months Allergy to stocking or compression cuff materials Unable to size or apply properly due to deformity, recent surgery or trauma FOOTNOTES AND PRECAUTIONS 1. Day surgery includes patients admitted and discharged within 24 hours for an elective surgical or invasive procedure. 2. In medical patients receiving anticoagulant prophylaxis, the NNT to prevent symptomatic DVT is 212 and non-fatal PE is 300; the NNH for major bleed is 430. There is no evidence for mechanical thromboprophylaxis in medical patients. 3. In surgical patients receiving anticoagulant prophylaxis, the NNT to prevent symptomatic DVT is and non-fatal PE is ; the NNH for major bleed is There is weak evidence for using mechanical thromboprophylaxis alone and weaker evidence for combining anticoagulant and mechanical prophylaxis to improve efficacy. 4. First post-op dose of anticoagulant should be given after hemostasis is achieved and as soon as it is safe to do so (usually hours after surgery). This should take into account the risks of bleeding, thrombosis and timing of subsequent surgery. 5. Prophylaxis for up to 30 days after surgery is recommended in those having hip replacement or hip fracture surgery, and up to 14 days after total knee replacement. Consider prophylaxis for up to 30 days after abdominal or pelvic surgery for cancer and in patients with multiple risk factors for VTE. 6. Heparin 5000 units subcutaneous Q12H should be used if patient is awaiting urgent surgery and is a candidate for neuroaxial blockade. Refer to Perioperative Pain Service or Anesthesia regarding timing of epidural catheter insertion and removal. 7. LMWH and heparin should not be given in patients with HIT. Consider consulting Hematology/Internal Medicine regarding the use of alternative agents (e.g. fondaparinux or argatroban). 8. If egfr is 10 to 30 ml/min AND expected LOS is longer than 10 days, consider using heparin instead of dalteparin. 9. Suggested dosing for dalteparin and heparin in patients with extremes of weight and/or severe renal impairment: Weight range dalteparin (if egfr 10 ml/min or above) heparin (if egfr less than 10 ml/min) 40 kg or less 2500 units subcutaneous once daily 2500 units subcutaneous Q12H 41 kg to BMI 40 kg/m units subcutaneous once daily 5000 units subcutaneous Q12H BMI over 40 kg/m units subcutaneous Q12H 5000 units subcutaneous Q8H VCH.RD.RH.0105 NOV.2014 CHART COPY Page 5 of 5